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Abstract 
Background. Puumala virus (PUUV) induced hemorrhagic fever with renal syndrome is common 
in many European countries. The typical renal histologic lesion is acute tubulointerstitial nephritis. 
We examined the type and kinetics of urine protein excretion, and prognostic significance of 
proteinuria for the severity of acute kidney injury (AKI) in acute PUUV infection. 
Methods. The amount of dipstick albuminuria at hospital admission was analyzed in 205 patients 
with acute PUUV infection. Dipstick albuminuria at admission was graded into three categories: 
0-1+, 2+, 3+. In 70 patients also 24-hour urinary excretion of protein, and overnight urinary 
excretion of albumin, immunoglobulin(Ig)G, and α1-microglobulin were measured over three 
consecutive days during the hospital stay. 
Results. Maximum median daily proteinuria, overnight albuminuria, and IgG excretion was 
observed five days, while that of creatinine values was observed nine days after the onset of the 
disease. The medians of maximum plasma creatinine levels during hospital stay were different in 
the 3 categories of dipstick albuminuria: 0-1+ 98 µmol/L (58-1499), 2+ 139 µmol/L (71-829), and 
3+ 363 µmol/L (51-1285) (p<0.001). Dipstick albuminuria ≥2+ at admission could detect 89% of 
the patients who subsequently developed severe AKI. Glomerular proteinuria, but not tubular 
proteinuria (α1-microglobulin), correlated with the severity of the emerging AKI. 
Conclusion. In acute PUUV infection, maximum median proteinuria values preceded the most 
severe phase of AKI by a few days. A highly useful finding for clinical work was that a quick and 
simple albuminuria dipstick test at hospital admission predicted the severity of the upcoming AKI. 
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Introduction 
Hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome 
(HCPS) are the manifestations of hantavirus infections in humans [1-3]. HFRS is caused by 
Eurasian hantaviruses, whereas HCPS occurs in the America [1-3]. These syndromes have also 
been referred to as “hantavirus fever”, as there are similarities in the clinical picture of the two 
syndromes [4,5]. Hantaan virus (HTNV) causes HFRS in Asia, whereas Puumala virus (PUUV) 
and Dobrava virus (DOBV) are distributed in Europe [1-3]. PUUV, spread by bank voles (Myodes 
glareolus), causes most of the HFRS cases in Europe [1-3]. PUUV infections are most common in 
Northern Europe, and high numbers of these infections are reported in Finland with 1000-3000 
serologically diagnosed cases annually. It is also common in Sweden, Belgium, Germany and 
Western Russia, but in many countries of Southern Europe, fewer cases are met [6,7]. 
The severity of hantavirus infections varies. HCPS can have a mortality of 35-50%, whereas 
HFRS caused by PUUV has a low mortality of 0.1% [2,8]. The three typical features in all HFRS 
cases are renal involvement, thrombocytopenia and increased capillary leakage [9-13]. In PUUV 
infection, the common clinical symptoms include sudden high fever with headache, abdominal and 
back pains, nausea, and visual disturbances, while serious hemorrhagic manifestations are rare [9-
13]. The disease often leads to hospitalization and sometimes to intensive care unit (ICU) treatment, 
including renal replacement therapy (RRT) and mechanical ventilation [14]. 
Renal involvement of PUUV infection causes transient proteinuria, microscopic hematuria, 
and frequently acute kidney injury (AKI). Oliguria or anuria is followed by polyuria, and thereafter 
spontaneous recovery takes place [9-13,15]. RRT is needed in up to 6% of the hospitalized patients 
[10-13]. There is a genetic predisposition to the severity of PUUV infection [16,17], and smokers 
develop a more severe AKI than non-smokers [18,19]. The outcome of the AKI in PUUV infection 
is favorable, i.e. without persisting sequelae [14]. 
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The typical renal histopathologic finding in PUUV-infection is acute tubulointerstitial 
nephritis, predominated by infiltrating lymphocytes, and also including plasma cells, monocytes, 
macrophages, and eosinophils [20,21]. Proteinuria is detected in almost all patients, which is of the 
nephrotic range in up to one-third of them [9-11,13,22]. The pathogenesis of this massive 
proteinuria is unclear. In a recent retrospective study from Germany, urinary neutrophil gelatinase-
associated lipocalin (NGAL) and urine albumin level predicted the severity of AKI in acute PUUV 
infection [23]. In this cohort, albuminuria was determined by urine albumin-creatinine ratio in 24 
patients and by dipstick in 59 patients, while tubular proteinuria was not addressed [23]. 
In the present study, our aim was to evaluate the prognostic significance of proteinuria on the 
severity of subsequent AKI in acute PUUV infection. Furthermore, we assessed the type and 
kinetics of proteinuria in relation to the course of PUUV infection. 
Subjects and Methods 
The cohort of this study consisted of 217 consecutive PUUV-infected patients treated at the 
Tampere University Hospital, Finland, during 1997-2014. The patients also participated in our 
previous studies [17,22,24-33]. All patients were examined during the acute phase of the disease, 
and the diagnosis of acute PUUV infection was serologically confirmed [34-37]. A detailed medical 
history was obtained and physical examination was performed. The median age was 41 (range 15-
77) years, 12 patients (7%) were older than 65 years, and 138 patients (67%) were males. Patients
<15 years of age were excluded. Also, 12 patients were excluded because of only one recorded 
creatinine value (5 patients) or missing urine dipstick test (7 patients). Altogether 205 patients were 
included in the analyses. 
The following diagnoses before acute PUUV infection had been made in 56 (27%) patients: 
hypertension (n=17), coronary artery disease (n=7), rheumatoid arthritis (n=5), diabetes (n=4), 
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bronchial asthma (n=4), hypothyroidism (n=4), celiac disease (n=3), inflammatory bowel disease 
(n=2), psychiatric disorder (n=2), operated malignant disease (n=2), cardiac conduction disorder 
(n=2), aortic/mitral valve disease (n=2), epilepsy (n=2), osteoporosis (n=2), sequelae of renal 
tuberculosis (n=1), polycystic kidney disease (n=1), operated meningioma (n=1), chronic lymphatic 
leukemia in remission (n=1), psoriasis (n=1), prostate hyperplasia (n=1), sleep apnea (n=1), and 
TIA (n=1). Some patients had more than one disease, but none had known prior kidney 
insufficiency. Although two patients had a history of a kidney disease, both of them had normal 
kidney function before PUUV infection. None of the patients were given non-steroidal anti-
inflammatory drugs in the hospital, but possible use before hospitalization was not recorded. All 
patients provided a written informed consent and the study was approved by the Ethics Committee 
of Tampere University Hospital. 
Laboratory determinations 
In all 205 patients, urine albumin dipstick test was performed at hospital admission, and daily 
plasma creatinine values during the hospital stay were determined (median number of 
determinations 5, range 2-15). The amount of albuminuria detected by dipstick test was graded into 
3 categories: 0-1+ (n=54), 2+ (n=73), and 3+ (n=78). In 70 consecutive patients treated during 
1997-1999, analyses of 24-hour urinary protein excretion, and overnight excretion of albumin, 
immunoglobulin (Ig)G, and α1-microglobulin were performed during 3 consecutive days. The 
highest and lowest values of the variables measured during hospitalization for each patient were 
designated as the maximum and minimum values, respectively. 
The diagnosis of PUUV infection in 1982-1989 was based on duplicate samples with 4-fold 
or greater rise in IgG-titer by the immunofluorescence assay (IFA) [34]. Since 1989, recent PUUV 
infection was confirmed from a single serum sample by detecting the typical granular staining 
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pattern in IFA [35], and/or low avidity of IgG antibodies to PUUV [36], and/or by detecting PUUV 
IgM antibodies by an ‘in-house’ enzyme-linked immunosorbent assay (ELISA) based on a 
recombinant antigen [37]. The development and use of the above and other diagnostic methods has 
been described by Vaheri et al [38]. 
Plasma creatinine was determined until 1999 by Vitros (Johnson & Johnson, Rochester, N.Y., 
USA) and thereafter by Cobas Integra (F. Hoffman- La Roche Ltd., Basel, Switzerland). Urine 
dipstick analysis was made by automated tests based on refractometry: From 1997 using Miditron 
M (Roche), from 2004 Urisys 2400 or 1900 (Roche), and from 2009 until 2014 Siemens Clinitec 
Atlas or Advantus. The sensitivity of these tests to urine albumin (1+) ranges 0.15-0.3 g/l. The 
dipstick result 2+ stands for ≥1 g/l albumin and 3+ ≥3 g/l albumin. The albumin dipstick tests do 
not react with urinary globulins or immunoglobulin light chains. Urine for the dipstick test was 
sampled on admission already at the emergency room. 
In 70 patients, urine collection was started on the first evening of hospital care and continued 
for 3 days. The nightly collection period was from the time of the last voiding at bedtime until the 
last voiding on rising. The 24-hour collection commenced immediately thereafter. The 24-hour 
urinary protein excretion was measured by the pyrogallol red molybdate method (Olli C.; Kone 
Instruments, Helsinki, Finland) until 1998, then by using Cobas Integra (Roche diagnostics) until 
2008, and thereafter using Cobas 8000 analyzer (Roche diagnostics). Timed overnight urinary 
excretions of albumin and 1-microglobubulin were measured using nephelometry (Behring 
Nephelometer II Analyzer, Behringwerke AG, Marburg, Germany). 
Blood cell count was determined by hematological cell counters (Bayer Diagnostics, Elkhart, 
IN, USA), and sodium, potassium, urea, and albumin concentrations using routine automated 
chemistry analyzers. All laboratory determinations were performed by the laboratory Centre of the 
Pirkanmaa Hospital District (later named Fimlab Laboratories), Tampere, Finland. 
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Statistical analyses 
Medians and ranges were given for skewed continuous variables and numbers and 
percentages for categorical variables. Spearman’s rank correlations were calculated. Categorical 
data were analysed by the x2 test or the Fisher’s exact test, and groups were compared using the 
Mann-Whitney U-test or the Kruskal-Wallis test, as appropriate. All tests were two-sided, and the 
analyses were performed using SPSS (version 20) statistical software (IBM, Chicago, IL). 
Results 
The clinical and laboratory data of the 205 patients are shown in Table 1. The median interval 
between the onset of symptoms (i.e. fever) and admission to hospital was 4 (range 1-15) days. 
Median duration of the hospital stay was 6 (range 2-25) days. Plasma creatinine was elevated (>100 
µmol/L) in 153 (75%) patients. Six patients (3%) were in clinical shock at admission. Nine patients 
(4%) needed RRT and among them the median creatinine concentration was 706 µmol/L (range 
265-1285). Among those treated with RRT, three subjects were in clinical shock and they had the 
lowest creatinine values (265-473 µmol/L) in this group of patients. After hospitalization two of 
these subjects were immediately transferred to the ICU for RRT due to oliguria or anuria, fluid 
retention and hypotension. None of the 205 patients had a urinary tract infection and all recovered. 
In 70 consecutive patients, 24-hour urinary protein excretion and overnight excretion of 
albumin, α1-microglobulin and IgG were measured over three consecutive days during the hospital 
stay. The maximum 24-hour urinary protein excretion ranged from 0.14 to 17.78 g/24h and was of 
nephrotic range (>3.5 g/24h) in 34% of patients. The highest 24-hour urinary protein excretion 
(peak median 1.67 g/24h, range 0.26-17.78) was detected on the fifth day after the onset of fever 
(Figure 1A). Glomerular proteinuria, i.e. overnight excretion of albumin (peak median 734 µg/min, 
range 12-7026) (Figure 1B) and overnight excretion of IgG (peak median 183 µg/min, range 6-
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1565) (Figure 1C) peaked on the fifth day as well. Tubular proteinuria, i.e. increased overnight 
urinary excretion of α1-microglobulin (>7 µg/min), was detected in 90% of the patients. The 
excretion was highest (peak median 38 µg/min, range 7-209) on the fourth day after the onset of 
fever (Figure 1D). Plasma creatinine value (peak median 229 µmol/L, range 68-725) was highest on 
the ninth day after the onset of fever (Figure 2). 
The maximum 24-hour urinary protein excretion correlated slightly with maximum plasma 
creatinine level (r=0.30, p=0.012), while there was a higher correlation between glomerular 
proteinuria (maximum overnight excretion of albumin and IgG) and maximum plasma creatinine 
level (r=0.41; p<0.001 and r=0.44; p<0.001, respectively). Tubular proteinuria (maximum overnight 
α1-microglobulin excretion) did not correlate with maximum plasma creatinine concentration 
(r=0.13; p=0.291). Maximum overnight α1-microglobulin excretion correlated with maximum C-
reactive protein (CRP) level (r=0.39; p=0.001), but not with other variables reflecting disease 
severity, i.e. length of hospital stay, weight change during hospital stay, maximum hematocrit, 
minimum platelet count, or maximum blood leukocyte count (data not shown). 
Table 2 shows the clinical and laboratory data of 205 patients according to the three groups of 
urine albumin dipstick test result at hospital admission. Patients with higher albuminuria by dipstick 
test had greater change in body weight during hospitalization, higher maximum hematocrit, lower 
minimum sodium concentration and lower minimum plasma albumin than patients with less or no 
albuminuria. The results of these findings reflect the degree of capillary leakage. They also had 
more severe AKI (higher maximum plasma creatinine, urea and potassium concentrations) and 
longer hospital stay, reflecting the severity of the disease. Higher albuminuria by dipstick at 
admission was associated with higher overnight urinary excretion of albumin and IgG, but not of 
α1-microglobulin. All of the above associations were statistically significant (for p-values see Table 
2). Platelet count was decreased (≤150 x109/L) in 197 patients (96%), but the minimum platelet 
count did not differ between the groups. The groups showed differences in the concentration of 
CRP, but CRP level was not associated with the amount of dipstick albuminuria. Higher category of 
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dipstick albuminuria was numerically related to higher 24-hour urinary protein excretion and lower 
plasma albumin, but these differences were not statistically significant. Among the 9 patients 
needing RRT, the dipstick albuminuria categories were 3+ in 6 subjects, 2+ in 1 subject, and 0-1+ 
in those two patients who were initially in clinical shock and treated at the ICU. 
To evaluate whether the duration of symptoms before admission to the hospital influenced the 
ability of urine albumin dipstick test to predict the severity of AKI, we divided the patients into two 
subgroups: admission on days 1-4 (128 patients) or on day 5 or later (77 patients) after the onset of 
fever. In both groups, the amount of dipstick albuminuria at admission was associated with median 
maximum plasma creatinine level: (1) admission on days 1-4: U-alb 0/1+ 96 µmol/L (range 52-
1499), U-alb 2+ 123 µmol/L (range 71-749), U-Alb 3+ 354 µmol/L (range 51-1285) (p<0.001); 
(2) admission on days ≥5: U-alb 0/1+ 118 µmol/L (range 58-874), U-alb 2+ 199 µmol/L (range 76-
829), U-alb 3+ 376 µmol/L (range 93-1153) (p<0.001). 
Severe stage 3 AKI (KDIGO, plasma creatinine ≥353.6 μmol/L [39]), was discovered in 63 
(31%) patients during the hospitalization. Albumin dipstick test ≥2+ at admission could detect 89% 
of those who subsequently developed severe AKI (creatinine≥353.6 μmol/L). Furthermore, albumin 
dipstick test 3+ at admission showed high positive predictive value of 82% for maximum plasma 
creatinine ˃200 μmol/L (median in the study population) with a negative predictive value of 69%. 
Discussion 
The present study showed that in acute PUUV infection, maximum proteinuria preceded the 
most severe phase of AKI by some days. Glomerular proteinuria, but not tubular proteinuria, 
correlated with the severity of AKI. To our knowledge, this finding has not been previously 
reported in HFRS. The amount of albuminuria detected by dipstick test at hospital admission 
predicted the severity of AKI in PUUV infection. It also associated with several other disease 
severity markers, many of which reflect the general capillary leakage typical of HFRS. 
10 
In previous times, when reliable serological testing was not yet readily available to diagnose 
acute PUUV infection, kidney biopsies were performed to verify the reason of AKI in PUUV-
infected patients. These biopsies have shown that the characteristic histological finding of acute 
PUUV-infection is acute tubulointerstitial nephritis [20,21]. Although intense proteinuria is not 
typical for tubulointerstitial nephritis, proteinuria in acute PUUV infection exceeds the nephrotic 
range in one-third of the patients [9-11,13,22], a finding that well corresponds with the present 
results. The contribution of tubular injury to the proteinuria in PUUV-infected patients is 
exemplified by the loss of low-molecular-weight proteins in the urine [40,41]. As kidney biopsies 
have usually been performed after the acute-phase thrombocytopenia has resolved to avoid biopsy-
related bleeding complications, the timing of the biopsies has probably influenced the renal 
histological findings of the disease. 
The glomerular alterations of acute PUUV infection in light-microscopy are minor [20], but 
the rapid onset of proteinuria suggests that alterations have taken place in vascular barrier function. 
The non-selective nature of the proteinuria indicates that the glomerular barrier is defective in acute 
PUUV-infection [40,41]. However, even in the case of massive transient proteinuria, the associated 
glomerular lesions with respect to adhesion molecules, cytokines, and cell infiltration remain 
negligible [21]. The hantaviruses can infect vascular endothelial cells, but also glomerular 
endothelial cells, tubular cells, and podocytes, disrupting the cell-to-cell contacts in all of these cell 
types [42]. Indeed, in electron microscopic studies, fusion of podocyte foot processes was already 
found in 1978 [43,44]. Recently, two reports confirmed severe ultrastructural changes in podocytes 
with foot-process effacement in 3 patients biopsied in the acute phase of hantavirus infection 
[45,46]. It seems plausible that podocyte dysfunction and disruptions of the cell-to-cell contacts 
impair the barrier function and result in intense glomerular proteinuria in the early phase of PUUV 
infection. In this study, glomerular proteinuria reached the highest values on the fifth day after the 
first clinical symptoms of the disease, and thereafter urine protein excretion decreased, suggesting 
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that proteinuria in this disease is rapidly resolving. However, we do not have data about urine 
protein excretion after hospitalization, and the disappearance of proteinuria in PUUV-infected 
patients is a subject for further studies. 
In the present study, many variables reflecting capillary leakage were associated with the 
amount of dipstick albuminuria at hospital admission (Table 2). Thus, glomerular proteinuria may 
reflect the increased capillary leakage in acute PUUV infection. The main hantavirus targets are the 
endothelial cells of the post-capillary venules in various organs [3,12], while increased vascular 
permeability is a typical finding in all hantavirus infections [47]. The pathogenesis of this has not 
been fully elucidated, but it may involve the release of bradykinin, which increases vascular 
permeability in various pathological conditions. Indeed, the selective bradykinin type 2 receptor 
antagonist, icatibant, was successfully administered in two cases of life-threatening PUUV infection 
[48,49]. In imaging studies of PUUV infected patients, signs of fluid accumulation and edema have 
been frequently found [50]. We previously reported that during the acute phase of PUUV infection, 
both renal parenchymal swelling and high arterial resistive index in renal ultrasound were 
associated with the severity of AKI [51,52]. The amount of urinary 24-hour protein excretion, 
however, was not associated with quantitative or qualitative findings in the renal ultrasound study 
[51,52]. In addition to capillary leakage, possible explanations to kidney swelling in acute PUUV 
infection are tubulointerstitial inflammation and medullary hemorrhages [20,21,46]. 
We found that maximum CRP level was not associated with the amount of albuminuria 
detected by the dipstick test. Inflammatory response may nevertheless have a major role in the 
pathogenesis of proteinuria and plasma leakage in HFRS. Maximum urinary protein excretion was 
found to correlate with plasma and urine interleukin (IL)-6 concentrations but not with complement 
activation in the acute phase of PUUV infection [22,27,53]. 
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Several mechanisms can lead to AKI during acute PUUV infection. In 17 French patients 
acute tubular necrosis (ATN) was the major histologic feature in 88% of cases, along with 
microvascular inflammation in peritubular capillaries [46]. Viral stimulus can trigger a major 
inflammatory response, causing tissue damage and ATN [54]. In kidney epithelial cell lines, 
apoptosis was reported in response to hantavirus infection [55,56]. Additional mechanisms of ATN 
in PUUV infected patients include hemodynamic alterations and intravascular hypovolemia, 
secondary to the capillary leakage. The use of non-steroidal anti-inflammatory drugs is another 
putative cause for ATN, and may contribute the severity of AKI in PUUV-infection [57]. These 
drugs were not given to the present patients at hospital, but possible usage before hospital 
admission was not recorded. 
In chronic glomerular diseases, non-selective proteinuria has been associated with tubular 
damage and progression of renal failure [58], but the role of glomerular proteinuria in the 
pathogenesis of AKI is unclear. Pre-existing proteinuria is a risk factor for AKI in various clinical 
situations [59]. Only few studies have examined the significance of de novo proteinuria during AKI. 
New onset urinary dipstick proteinuria was associated with severe AKI in critically ill septic 
patients [60], and with increased risk of developing AKI in patients with severe burns [61]. In 
cardiac surgery patients, high amount of postoperative dipstick proteinuria was associated with the 
risk of AKI [62]. In our study, glomerular proteinuria correlated with the severity of upcoming AKI, 
but tubular proteinuria did not. Further, the peak excretion of albumin and IgG preceded the most 
severe phase of AKI by four days. Thus, alterations in glomerular permeability reflect the severity 
of upcoming AKI in acute PUUV infection. As a limitation of the present study, the type of 
proteinuria could only be evaluated in one-third (70/205) of the patients. 
In a recent study, aimed at identifying patients who are at lower risk of developing severe 
AKI during acute PUUV infection, albuminuria defined by a urine albumin/creatinine ratio (ACR) 
>0.25g/g was one of the three risk-factors that predicted the risk of AKI [63]. The other two factors 
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were thrombocytopenia and the level of CRP [63]. Urinary NGAL was also found to predict the 
severity of AKI in PUUV infection [23]. When compared with urine ACR and NGAL 
determinations, albumin dipstick test is quick, inexpensive, and readily available. As albumin 
dipstick test result ≥2+ at hospital admission identified 89% of the patients who subsequently 
developed severe AKI, this simple test is a clinically applicable tool for the evaluation of severe 
AKI risk and the need for hospital treatment. Of note, the preceding duration of the symptoms of 
PUUV-infection did not influence the ability of urine albumin dipstick test to predict the severity of 
upcoming AKI. 
In conclusion, maximum proteinuria preceded the most severe phase of AKI by some days in 
acute PUUV infection. Glomerular proteinuria, but not tubular proteinuria, correlated with the 
severity of the emerging AKI. The influence of proteinuria on the mechanisms of AKI during 
hantavirus infections is an interesting subject for further investigations. Finally, the determination of 
albuminuria by urine dipstick test at hospital admission predicted the severity of upcoming AKI in 
acute PUUV infection. It also associated with several variables that reflect increased capillary 
leakage. The predictability of this simple test should be evaluated in more severe HFRS cases 
caused by HTVN in Asia or DOBV in Europe, and in patients with HCPS in the Americas. 
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Table 1. The clinical and laboratory characteristics of 205 patients with acute Puumala 
hantavirus infection. 
Finding Median Range 
Age years 41 15-77 
Duration of fever, days 6 2-19 
Length of hospital stay, days 6 2-25 
Body weight change during hospital stay, kg* 2.4 0-12 
Hematocrit max 0.44 0.33-0.60 
Platelets min, ×109/L 61 3-249 
Leukocytes max, ×109/L 10.4 4.2-45.0 
Plasma CRP max, mg/L 79 16-269 
Plasma creatinine max, mol/L 200 51-1448 
Plasma urea max, mmol/L (n=110) 17.7 2.1-52.8 
Sodium min, mmol/L 132 109-142 
Potassium max, mmol/L 4.3 3.3-5.5 
Plasma albumin min, g/L (n=113) 27 11-39 
Urinary protein excretion max, g/24h (n=70) 1.80 0.14-17.78 
Overnight urinary albumin excretion max, μg/min (n=70) 760 4-7026 
Overnight urinary IgG excretion max, μg/min (n=70) 173 3-1565 
Overnight urinary α1-microglobulin excretion max, μg/min (n=70) 28 2-209 
*Difference between the highest and lowest weight during hospital stay; min=minimum,4 
max=maximum, CRP=C-reactive protein, IgG=immunoglobulin G.5 
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Table 2. Clinical and laboratory data of 205 patients divided into three groups according to urine dipstick protein category at hospital admission. 
U-alb 0/1+ U-alb 2+ U-alb 3+ p-value 
Number of patients 54 73 78 
Age, years 41 (22-77) 43 (22-74) 40 (15-65) 0.294 
Length of hospital stay, days 5 ( 3-22) 6 (3-15) 7 (2-14) 0.026 
Body weight change during hospital stay, kg* 1.6 (0-10.8) 2.2 (0-10.0) 3.7 (0-12.0) <0.001 
Hematocrit max 0.42 (0.33-0.59) 0.44 (0.34-0.59) 0.46 (0.34-0.60) 0.001 
Platelets min, ×109/L 68 (3-249) 61 (15-198) 56 (5-187) 0.232 
Leukocytes max, ×109/L 9.2 (5.1-38.6) 9.0 (4.2-31.2) 13.0 (5.7-45.0) <0.001 
Plasma CRP max, mg/L 74 (16-236) 92 (20-269) 68 (21-214) 0.012 
Plasma creatinine max, mol/L 98 (52-1447) 139 (71-829) 363 (51-1285) <0.001 
Plasma urea max, mmol/L (n=110) 9.9 (2.0-52.4) 13.3 (3.9-39.7) 25.7 (2.7-52.8) <0.001 
Sodium min, mmol/L 135 (109-141) 133 (120-141) 130 (113-142) 0.001 
Potassium max, mmol/L 4.1 (3.3-5.2) 4.2 (3.3-5.3) 4.4 (3.3-5.5) 0.001 
Plasma albumin min, g/L (n=113) 30 (11-39) 28 (21-37) 27 (18-37) 0.161 
Urinary protein excretion max, g/24h (n=70) 0.57 (0.14-9.50) 1.74 (0.18-17.78) 2.22 (0.30-10.00) 0.076 
Overnight urinary albumin excretion max, μg/min (n=70) 104 (4-4617) 756 (12-6246) 1016 (136-7026) 0.007 
Overnight urinary IgG excretion max, μg/min (n=70) 16 (7-1267) 211 (3-1565) 226 (25-1542) 0.005 
Overnight urinary α1-micro-globulin excretion max, μg/min (n=70) 20 (10-89) 38 (9-209) 30 (2-130) 0.693 
Values are expressed as medians (range), * Difference between the highest and lowest weight during hospital stay; min=minimum, 
max=maximum, CRP=C-reactive protein.
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Legends to the figures 
Figure 1. Scatter plots show 24-hour urinary excretion of protein (A), overnight urinary excretion 
of albumin (B), immunoglobulin (Ig) G (C), and α1-microglobulin (D) in relation to the onset of 
fever in 70 PUUV infected patients; panels A-D depict values on three consecutive days in each 
patient. Every circle represents one measurement, the line depicts median values, outliers and 
extremes are omitted. 
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Figure 2. Scatter plot shows plasma creatinine values in relation to the onset of fever in 70 PUUV 
infected patients during hospital stay. Every circle represents one measurement, the line depicts 
median values. 
 
 
